|
| 'Chitosan (1) | 1 (2) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
| 12-Dimethylbenz[a]anthracene (1) | 18 β-glycyrrhetic acid (1) | 2 (2) |
| 2, 5-diaza bicyclo [4.3.1] compounds (1) | 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) |
| 2-aminobenzothiazole (1) | 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) |
| 25(OH)2D (1) | 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) |
| 32 factorial design (1) | 3D bio-ink printing (1) | 3D QSAR (1) |
| 3D-QSAR (1) | 3’ UTR region (1) | 4 - acetamido phenoxy acetyl hydrazide (1) |
| 4-dihydroxy-4-methoxybenzophenone- 2-O-β-d-glucopyranoside (1) | 4-pyridinecarboxylic acid hydrazide (1) | 4-Thiadiazole-2-amine (1) |
| 5-fluoroindolin-2-one (1) | 5-Fluorouracil (1) | 5-HT 3 receptor antagonists (1) |
| 5-Piperazinedione (1) | 6 (1) | 6-beta naltrexol (1) |
| 6-Mercaptopurine (1) | 6-Methylmercaptopurine (1) | 6-tetrahydropyridine (MPTP) (1) |
| 7 (1) | 7-Hydroxy warfarin. (1) | 8-iso-Prostaglandin F2α (1) |
| 99mTc-ciprofloxacin (1) | A. nilotica (1) | ABC analysis (5) |
| ABC-VED matrix (4) | ABC-VEN analysis (1) | Abdominal pain (1) |
| Abdominal Pregnancy (1) | Abheshaja (1) | Absorbance ratio (1) |
| Absorption ratio (1) | Abstinence (1) | ABTS (1) |
| Abuse (1) | Academic Stressors scale (1) | Acalypha indica (1) |
| Acarbose (1) | Accuracy. (1) | Accurate (1) |
| ACE (2) | ACE inhibitor (1) | Aceclofenac (1) |
| ACEIs (1) | Acetaminophen (1) | Acetazolamide (1) |
| Acetic acid induced rat colitis (1) | acetic acid induced writhing test (1) | Acetyl cholinesterase estimation (1) |
| Acetyl isoniazid (1) | Acetylation rate (1) | Acetylcholinesterase (4) |
| Acetylcholinesterase inhibitors (1) | ACF (1) | Achillea millefolium L. (1) |
| Acid hydrolysis (1) | Acid violet 43 (1) | Acid-resistant capsules (1) |
| Acne (2) | Acne vulgaris (1) | Aconitine (1) |
| Acquired immune deÞ ciency syndrome (1) | Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) | Act score (1) |
| Actinomycetes (1) | Activator procaspase-3 (1) | Active metabolites (1) |
| active pharmaceutical ingredient (1) | Active site (1) | Activities of daily living (ADL) scale (1) |
| Activity domain (1) | Acupuncture (1) | Acute appendicitis (1) |
| Acute generalized exanthematous pustulosis (1) | Acute Inflammation (1) | Acute inß ammation (1) |
| Acute Kidney Damage (1) | Acute poisoning (1) | Acute Severe Pancreatitis (1) |
| Acute Side Effects (1) | Acute ST segment elevation myocardial infarction (1) | Acute toxicity (1) |
| acyclovir (2) | Adapalene (1) | ADE (1) |
| Adenanthera (1) | Adenosine A 2A antagonist (1) | Adherence (5) |
| Adherence. (1) | Adiantum venustum (1) | Adjuvant therapy (1) |
| ADME properties. (1) | Adnexal masses (1) | ADR (2) |
| ADR (Adverse Drug Reaction) (3) | ADR management (1) | ADR monitoring centre (AMC). (1) |
| ADR reporting (1) | ADR(Adverse Drug Reaction) (1) | ADRs (2) |
| Adsorbent (1) | Adverse drug event (1) | adverse drug events (1) |
| Adverse drug reaction (15) | Adverse Drug Reaction (ADR) (1) | Adverse Drug Reaction and Antihypertensive medications. (1) |
| Adverse Drug Reaction Reporting Systems (2) | Adverse drug reaction. (1) | Adverse Drug Reactions (10) |
| Adverse drug reactions (ADRs) (1) | Adverse effects (1) | Adverse event following immunization (AEFI) (1) |
| Adverse events (2) | Adverse reaction (1) | Aedes aegypti (2) |
| Aedes aegypti L (1) | Aedes albopictus (1) | Aerobic exercise (1) |
| Aerosil (1) | affective ; assessment ; cognitive ; learning domains ; psychomotor (1) | Age (2) |
| Ageratum conyzoides L (1) | Agrobacterium (1) | air pollution (1) |
| Airjet (1) | Albendazole (1) | Albino mice (1) |
| Albino wistar rats (1) | Albumin Denaturation (1) | Alcohol (3) |
| Alcohol withdrawl seizure (1) | alcoholic extract (1) | ALDEN (1) |
| Aldose reductase inhibitors (1) | Alkaloids (1) | allantoin (1) |
| Allergic reactions (1) | Allergic rhinitis (1) | Allergy (4) |
| Allium sativum (1) | Alloxan (1) | Alloxan monohydrate (1) |
| Alocasia indica Schott (1) | Aloe vera (1) | Alpha mangostin (1) |
| Alpha-adrenoceptor (1) | alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) |
| Alprazolam (1) | Alteration of drug cost (1) | Altered Mental Status (AMS) (1) |
| alternative therapy (1) | Aluminium chloride (2) | Alzheimer's disease (1) |
| Alzheimers disease (1) | Alzheimer’s disease (1) | Amaranthus spinosus Linn (1) |
| Amber (1) | Ambroxol hydrochloride (1) | Ambulatorial Surgery Procedures (1) |
| Amides (1) | Amikacin Sulfate (1) | Amino acids (1) |
| amino benzylated Mannich bases (1) | Amisulpride (1) | amivudine (1) |
| Amlodipine (2) | Amlodipine besylate (2) | Ammonium salts (1) |
| Amoora cucullata. (1) | amoxicillin (1) | Amoxicillin - clavulanic acid (1) |
| Amoxicillin sodium (1) | Anabolic steroids (1) | Anabolic. (1) |
| Anaemia (2) | Analgesia (1) | analgesic (10) |
| Analgesic effect (1) | analgesic- anti-inß ammatory activity (1) | Analgesics (1) |
| Analysis in capsules (1) | Analysis of variance (1) | Analytical methods (1) |
| Anaphylactic shock (1) | Anaphylaxis. (1) | and TGF–β (1) |
| Andragogy (1) | Anemia (2) | Anethole (1) |
| Anethum graveolens (1) | Angiogenesis (1) | Angiogenic growth factors (1) |
| Angiotensin Converting Enzyme Inhibitors (1) | Animal model (1) | Ankylosing spondylitis (1) |
| antepartum (1) | anthelmintic (1) | anthelmintic property (1) |
| Anthocyanin (1) | Anthracyclines (2) | Anti aging (1) |
| Anti hyperglycemic (1) | Anti inflammatory (1) | Anti-amnesia (2) |
| anti-anxiety activity (1) | Anti-anxiolytic (1) | Anti-asthmatic activity (1) |
| Anti-Cancer Activity (1) | Anti-diabetes mellitus. (1) | Anti-diabetic drugs (1) |
| Anti-diabetics (1) | Anti-epileptic (1) | Anti-epileptic drugs utilization (1) |
| Anti-HIV (2) | anti-hypertensive agent (1) | Anti-infective (2) |
| Anti-infective agents (1) | anti-inflammation (1) | anti-inflammatory (7) |
| Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) | anti-inflammatory activity (2) | anti-inflammatory activity', (1) |
| anti-inflammatory agent (1) | anti-inß ammatory (3) | Anti-inß ammatory activity (1) |
| Anti-obesity (1) | Anti-oxidant (2) | Anti-parkinsonism activity (1) |
| Anti-solvent (1) | anti-spasmodic drug (1) | Anti-TB drugs (1) |
| Anti-tubercular activity (1) | Anti-tumor agent (1) | antiamnesic agents (1) |
| Antianxiety (1) | antibacterial (3) | antibacterial activity (4) |
| Antibacterial drugs (1) | Antibiotic (2) | Antibiotic Drug utilization (1) |
| antibiotic guidelines (1) | Antibiotic paste (1) | Antibiotic Resistance (3) |
| Antibiotic Sensitivity (1) | Antibiotics (11) | Antibiotics. (1) |
| Anticancer (5) | Anticancer activity (1) | Anticancer drugs (1) |
| Anticholinergic (1) | Anticoagulant (2) | Anticoagulant service (1) |
| anticonvulsant (1) | anticonvulsant activity (1) | anticonvulsants (1) |
| Anticovulsant (1) | Antidepressants (1) | Antidesma bunius (1) |
| Antidiabetic (3) | Antidiabetic activity (2) | Antidiabetic agents (1) |
| Antiepileptic (1) | antiepileptic agents (1) | Antiepileptic Drugs (3) |
| antifungal (1) | antifungal activity (1) | Antifungal drugs (1) |
| Antigen (1) | antigen protein (1) | Antiglycation (1) |
| Antihistaminic (2) | Antihyperglycemic (1) | Antihypertensive (1) |
| Antihypertensives (1) | Antiinflamatory (1) | Antimalarial (2) |
| Antimicrobial (5) | Antimicrobial activities (1) | Antimicrobial activity (7) |
| Antimicrobial agent (1) | Antimicrobial efficacy (1) | Antimicrobial Plants (1) |
| Antimicrobial resistance (2) | Antimicrobial resistance; Prescribing practice; Anti-infective agents; Antibacterials; Pharmacoepidemiology. (1) | Antimicrobial Stewardship (1) |
| Antimicrobials (4) | Antimosquito (1) | Antimycotic Activity (1) |
| antinociceptive (1) | Antioxidant (21) | Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) |
| Antioxidant activity (9) | antioxidant effect (1) | Antioxidant properties (1) |
| Antioxidants (6) | Antipsychotics (1) | antipyretic (2) |
| Antiretroviral drugs (1) | Antiretroviral therapy (2) | Antispasmodic (1) |
| Antithrombotic (2) | Antithyroid drugs (1) | Antitubercular (1) |
| Antitubercular drugs. (1) | antiulcer (1) | Antiurolithiatic activity (2) |
| Antivenom (1) | Antivenom reactions (1) | Antiviral (2) |
| antiviral activity (2) | Antiviral RNA (1) | Anti– microbials (1) |
| Anxiety (4) | Anxiety disorder (1) | Anxiolytics (1) |
| APAP (1) | APC (1) | Apoptosis (2) |
| Application (1) | Application to PK profile studies (1) | applications (1) |
| Appropriateness (1) | Aqueous extract (3) | AR Caps (1) |
| Arabic gum (1) | ARBs (1) | ARDS (1) |
| Area above the blood glucose levels-time curve. (1) | area of wound healing (1) | Areca nut (1) |
| Arginase (2) | Arginine (1) | Aripiprazole (1) |
| Armodafinil (1) | ART (1) | Artemia salina (1) |
| Artemia salina. (1) | Artemisia (1) | Artemisia absinthium (1) |
| Artemisia macrocephala (1) | arterial hypertension (1) | Arterial stiffness (2) |
| Arteriovenous malformation (AVM) (1) | Arthralgia (1) | Arthritis (1) |
| ARV Drugs (1) | Ascorbic acid (3) | Asenapine (1) |
| asian developing nations (1) | Asiaticoside (1) | Asparagus racemosus (1) |
| Asparagus racemosus root extract (1) | Aspergillus niger (2) | Aspergillus niger. (1) |
| Aspergillus terreus (1) | Aspirin (1) | Assay (2) |
| Assessment (1) | Asthma (6) | Asymptomatic neurocognitive impairment (1) |
| Ataxia (3) | ATC/DDD (3) | Atenolol (1) |
| Atherosclerosis (1) | Atherosclerotic Vascular Disease (1) | Athlete Biological Passport (1) |
| Atorvastatin (5) | Atorvastatin calcium (1) | Atorvastatin. (1) |
| ATP synthase inhibitor (1) | ATP- sensitive K+channel (1) | Atractylis flava Desf (1) |
| Atrial fibrillation (1) | Atropine (1) | Attitude (7) |
| Attitude and practice (1) | Attitude. (1) | Attitudes (2) |
| Atypical antipsychotics (1) | Aucubin (1) | Authors (1) |
| Authorship issues (1) | Autism spectrum disorders (1) | Auto antibody (1) |
| Auto medication (1) | Autoimmune disorders (1) | Autoimmunity (1) |
| Averrhoa bilimbi (1) | Avicel (1) | Awareness (6) |
| Ayurveda (2) | Ayurvedic (1) | Azelaic acid (1) |
| Azilsartan medoxomil (1) | B cell epitope (1) | Back pain (1) |
| Bacoside A3 (1) | Bacteremia (1) | Bacteria (1) |
| Bacterial contamination (1) | Bacterial isolates (1) | Bacteriological culture (1) |
| Bacteriostatic (1) | Baker Venkataraman transformation (1) | Bamboo betung (1) |
| Bambusa vulgaris (1) | Banana (1) | Bangladesh (2) |
| bark (1) | Barleria cristata (1) | Barriers (1) |
| Bauhinia purpurea (1) | Bauhinia racemosa (1) | Bauhinia variegata (2) |
| Bay-K-8644 (1) | Bayesian confidence propagation neural network (1) | BCG vaccine (1) |
| BCS-IV drug (1) | Beauty Salon Owner (1) | Beck Depression Inventory (1) |
| Beck Depression Inventory(BDI) (1) | Bedaquiline (1) | Behavioral research (1) |
| Belief (1) | Benchmarking (1) | Benzimidazole derivative (1) |
| benzimidazoles (2) | Benzodiazepines (1) | Benzothiazole analogues (1) |
| Benzo[d]oxazole-2-thiol (1) | Berberis integerrima Bunge (1) | Beta-lactamase (1) |
| Beta-lactamic (1) | Bibliometrics (6) | BIBN4096 (1) |
| Bilayered floating tablets (1) | Bioactive compound (1) | Bioactive Metabolites (2) |
| Bioactivity (1) | Bioadhesive (1) | Bioanalytical (1) |
| Bioanalytical method (2) | Bioanalytical method development (1) | Bioassay (1) |
| bioavailability (6) | Biodegradable (1) | Bioethics (1) |
| Biofilm (1) | Biohazard (1) | Biologics (1) |
| Biology (1) | Biomaterials (1) | Biomedical (1) |
| Bioprospecting. (1) | Biopsy Proven Acute Rejection (1) | Biosafety (1) |
| Biosafety Engineering Control (1) | Biosimilars (2) | Biotechnology (2) |
| Bisphosphonates (1) | Bitter (1) | Black Garlic (1) |
| Black tea extract (1) | BLAST (1) | Bleaching (1) |
| Bleeding time (1) | Bleomycin (1) | Blonanserin (1) |
| Blood brain barrier (1) | Blood donor (1) | Blood glucose (1) |
| Blood pressure (4) | Blood safety (1) | Blue and red from (1) |
| Body Mass Index (1) | Body Mass Index (BMI). (1) | Boerhaavia Diffusa (1) |
| Bone (2) | Book Review (1) | Borg scale (1) |
| botulinum toxin (1) | Box-Behnken (1) | Brahmi vati (1) |
| Brain (1) | Brain targeting (2) | Brand Drugs (1) |
| brand name drugs (1) | Branded medication (1) | Bratton-Marshall reagent (1) |
| Brazil (1) | Breast cancer (6) | Breastfeeding (2) |
| Brewer’s yeast (1) | Brief COPE scale (1) | Brief medication questionnaire (1) |
| Brimonidine tartrate (1) | brine shrimp lethality bioassay (1) | Brine-shrimp lethality. (1) |
| Broad spectrum antibiotics (1) | Brochures (1) | Bromelain (1) |
| Bromeliaceae (1) | Bromocresol purple (1) | Bronchial Asthma (2) |
| Bryonia laciniosa (1) | Buccal (1) | Buccal Patches (1) |
| budget forecasting (1) | Bufadienolide (1) | Bullous eruption (1) |
| bungarotoxin (1) | Bungarus caeruleus (1) | Bungur (1) |
| Buni-berry extract (1) | Buoyancy (1) | Buoyant microspheres (1) |
| Burden Of Disease (1) | Burn wound (1) | Business method (1) |
| Business model (1) | Butea monosperma (1) | C-reactive protein (1) |
| C. albicans (1) | C60 derivatives (1) | C934 (1) |
| CA125 (1) | Ca2+ channels (1) | Cadmium chloride (1) |
| Caesalpinia decapetala (1) | Caesalpinia pulcherrima (1) | Caesalpinia pulcherrima (L.) Sw. stem bark (1) |
| Caesalpinia sappan (1) | CAGR (1) | Calcineurin inhibitor (1) |
| Calcium (2) | Calcium channel blocking (1) | calcium channel blocking activity (1) |
| Calcium oxalate (1) | Calcium phosphate (1) | Calcium silicate (1) |
| Calendula officinalis (1) | calendula oil (1) | CAM Assay (1) |
| Camelia sinensis extract (1) | Camellia sinensis (1) | Camptothecin (1) |
| Canagliflozin (1) | Cancer (7) | Cancer Chemotherapy (2) |
| Cancer treatment (1) | Candida (2) | Candida albicans (4) |
| Candida albicans. (1) | CaOx crystal aggregation (1) | CaOx crystal nucleation (1) |
| Capacity (1) | Capsule (1) | capsules (1) |
| carbamazepin (1) | Carbamazepine (3) | carbohydrazide (1) |
| Carbomyl Linkage (1) | carbon tetrachloride (2) | carbonyl compounds (1) |
| Carbopol (1) | Carbopol 940 (1) | Carcinogenic substances (1) |
| Carcinoma. (1) | cardiac arrhythmias (1) | Cardiac care (1) |
| Cardiac complication (1) | Cardiac remodeling (1) | Cardiology (2) |
| Cardioprotection (1) | Cardioprotective (1) | Cardiotoxicity (2) |
| Cardiovascular disease (1) | Cardiovascular drugs (1) | Career Choices (1) |
| Carica papaya L. (1) | Carnaúba (1) | Carnauba wax (1) |
| carrageenan (2) | Caryocar coriaceum (1) | Case report (1) |
| Casein (1) | Casein Phosphopeptide-amorphous calcium Phosphate (1) | Catalase (1) |
| catalepsy (2) | Cation-pi (1) | CationicGuargum (1) |
| Caulerpa lentillifera (1) | Causality assessment (2) | Causality scales (1) |
| CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) | CCl4 (1) | CD150 (1) |
| CD244.2 (1) | CD48 (1) | Cefixime (1) |
| Cefotaxime (1) | ceftriaxone and co-amoxiclav (1) | Cefuroxime (1) |
| Cefuroxime Axetil (1) | cell viability Glycyrrhiza glabra (1) | Cellulase (1) |
| Cellulite (1) | Cellulitis (1) | Cellulose (2) |
| Cemented (1) | Cementless (1) | CEN (1) |
| Centella asiatica (3) | Central composite design (4) | Central cord syndrome (1) |
| Central post-stroke pain (1) | Cephalexin (2) | Ceramics (1) |
| Cerebrovascular Accident (1) | Cervical bulge (1) | Cervical dentine hypersensitivity (1) |
| Cervical lymphadenopathy (1) | CFFF (1) | CGRP (1) |
| chalcone (1) | chalcones (2) | Challenges (1) |
| Chamomile tea (1) | Characterization (4) | Chebulinic acid (1) |
| Chemical stability (1) | Chemiluminescence (1) | Chemomechanical removal (1) |
| Chemometrics (3) | Chemotaxis (1) | Chemotherapy (7) |
| Chewable tablets (1) | Chewing gum (1) | Child Care (1) |
| Childhood cancer (1) | Children (3) | Children and youth (1) |
| Children Dentistry (1) | Chitin (1) | Chitosan (8) |
| Chitosan Acetate. (1) | chitosan microspheres (1) | Chitosan nanoparticle (1) |
| Chitosan-g-HPβCD (1) | Chlamydomonas reinhardtii (1) | Chloramphenicol (1) |
| Chlorhexidine (2) | Chlorohexidine (1) | cholesterol (1) |
| Cholesterol HDL (1) | Cholinesterase inhibitors (1) | Chromatography (1) |
| Chromotropic acid reagent (1) | Chronic hepatitis B (1) | Chronic kidney disease (2) |
| Chronic Obstructive Pulmonary Disease (COPD) and Elderly Patient. (1) | Chrysophyllum cainito L. leaves (1) | Cicer arietinum (1) |
| Cigarette smoke (1) | Cilostazol (1) | Cinnamaldehyde (1) |
| Cinnamic acid derivatives (1) | Cinnamomum cassia (1) | Ciprofloxacin (2) |
| Citronella (1) | Citrus hystrix (1) | Citrus limon (2) |
| CKD (1) | CKMB. (1) | Claims (1) |
| Clarithromycin (1) | Classification (1) | Clastogenicity (1) |
| Cleistanthin A (3) | cleistanthin B (3) | Cleistanthus Collinus (2) |
| Clinic Epidemiology (1) | Clinical attachment (1) | Clinical attachment level (1) |
| Clinical efficacy (1) | Clinical equivalence (1) | Clinical manifestation (1) |
| Clinical Pharmacist (1) | Clinical pharmacist care (1) | Clinical Pharmacists (1) |
| Clinical pharmacology (1) | Clinical Pharmacy (1) | Clinical Pharmacy Services (1) |
| Clinical research (1) | Clinical symptoms (1) | Clinical trial (1) |
| Clinical trials (1) | Clinicians (1) | clonidine (2) |
| Clopidogrel (1) | Clopidogrel bisulfate (1) | Closed melt (1) |
| Clove (1) | cloxacillin (1) | Cluster analysis (1) |
| CME (1) | CNC (1) | CNF (1) |
| CNS stimulants (1) | Co-crystal (1) | Co-Formers (1) |
| Co-Morbidity (1) | Co-morbidity. Correspondence (1) | co-precipitation method (1) |
| Co-surfactant (1) | Cochlopermum tinctorium (1) | coding system (1) |
| Cognition (2) | Cognitive impairment (1) | Cogrinding (1) |
| Colloidal carriers (1) | Colloidal silicone dioxide (1) | Colon targeted delivery (1) |
| Colon targeted drug delivery. (1) | Colon targeting (1) | Colonic delivery (1) |
| Colonoscopy (1) | Colorectal cancer (1) | colorimetric assay (1) |
| Column chromatography (1) | Combination tablet (1) | Combination Therapy (1) |
| Combinatorial effect (1) | Comet assay (1) | common cold (1) |
| common cold and cough (1) | Common warts (1) | Community Pharmacies (2) |
| Community pharmacist (3) | Community Pharmacists (2) | Community pharmacy (3) |
| Community Pharmacy Patient Questionnaire (1) | Comorbid (1) | Comorbidity (1) |
| Comparative dissolution (1) | comparative molecular similarity indices (1) | comparative molecular Þ eld analysis (1) |
| Comparison (1) | compensation (1) | Complementary and alternative medicine (2) |
| complementary and alternative medicines (1) | Complementary and alternative therapy (1) | complete epithelization (1) |
| Complexation (1) | Compliance (1) | compound 48/80 (2) |
| compritol 888 ATO (1) | Computer (1) | Computer literacy (1) |
| computer-aided instructions (1) | Computer-aided learning (1) | Computerized screening systems (1) |
| CoMSIA (1) | Cone-beam tomography (1) | Conessine (1) |
| Constipation (1) | Consumer (1) | Consumer perception (1) |
| Consumer side effects reporting from (1) | Consumer’s Perception (1) | Content validation (1) |
| content validity (1) | continuing education (2) | Continuous Pharmacy Education. (1) |
| Contract research (1) | Contract research organizations (1) | Control (1) |
| Controlled release (4) | convolution (1) | convulsions (1) |
| cooperative practice (1) | COPD (2) | Coprocessed excipient (1) |
| Cordia obliqua (1) | Corneal bacterial ulcers (1) | Corneal opacities (1) |
| Coronally advanced flap (1) | Coronavirus disease (1) | Correlation (2) |
| Corticosteroid (2) | Corticosteroids (2) | Cosmetic (2) |
| Cosmetic products (1) | Cosmetics (1) | Cosmetics use-related adverse reactions (1) |
| Cosolvency (1) | Cost analysis (1) | Cost avoidance (1) |
| Cost Minimization (1) | Cost of illness (2) | Cost saving (1) |
| Cost-effectiveness analysis (1) | Cost. (1) | Costing Analysis. (1) |
| Cotton dust (1) | Cotton oil (1) | cotton pellet (1) |
| Cough (1) | Cough medicine (1) | cough. (1) |
| Counterfeit Pharmaceutical Products (1) | COVID-19 (3) | CPs (1) |
| Cramer’s Matrix method (1) | CRC (1) | Cream (1) |
| creatinine (1) | Crinum asiaticum (1) | CRISPR/Cas9 (1) |
| Critical Care Unit (CCU) (1) | Critical Material attributes (1) | Critical material attributes (CMAs) (1) |
| Critical Quality Attributes (1) | Critical quality attributes (CQAs) (1) | Critical Thinking (1) |
| cromolyn sodium (1) | Cronbach’s alpha (1) | Croscarmellose sodium (CCS) (1) |
| Crospovidone (1) | Crospovidone (CP) (1) | Cross carmellose sodium (1) |
| cross-linking agents (1) | Cross-sectional study (1) | Crossandra (1) |
| Croton zehntneri (2) | Crystallinity (2) | CTCAE (2) |
| CTEPH (1) | Cucumis metuliferus (1) | Cucumis sativus (1) |
| Culex quinquefasciatus (1) | CUMIN. (1) | Cuminosides (1) |
| Curcuma longa (1) | Curcumin (3) | current indian scenario of drug interactions (1) |
| Curriculum (1) | curriculum development (1) | Cutaneous Adverse Drug Reactions (CADRs) (1) |
| Cutaneous reaction (1) | CXCR4 (1) | Cyclodextrin (1) |
| Cyclooxegenase-2 inhibitor (1) | Cyclooxygenase (2) | cyclophosphamide (1) |
| Cymbopogon citratus (1) | Cynodon dactylon (2) | CYP genes ; South Indian population ; polymorphisms (1) |
| Cyst (1) | Cytochrome P 2C9 (1) | Cytosine (CYS) (1) |
| Cytotoxic (1) | Cytotoxic activity. (1) | Cytotoxic agents (1) |
| Cytotoxicity (3) | CZE (1) | D&C (1) |
| D-optimal design (1) | Daily Defined Dose (1) | Dammam (1) |
| Dapsone (1) | Data mining algorithms (1) | DDD (1) |
| DDX3 (1) | Death Receptors (1) | Decision making (1) |
| Deep vein thrombosis (1) | deferasirox (1) | deferiprone (1) |
| Deficiency (1) | Definitive screening design (DSD) (1) | Degenerative disc disease (1) |
| Degradation (1) | Degradation studies (1) | Dehydrozingerone (1) |
| Delignification (1) | Delirium (2) | Dementia (1) |
| democratic government (1) | Dengue (1) | Dengue high fever (1) |
| Dental caries (5) | Dental Caries. (1) | Dental decay (1) |
| Dental implants (1) | dental management (1) | Dental Prosthesis (2) |
| Dental prosthesis. (1) | Dental Restoration (1) | Dental Students (1) |
| Dentistry (3) | dentistry. (1) | Dentists (1) |
| Denture Stomatitis (1) | Deodorants (1) | Dependence (1) |
| Depigmentant (1) | Depok Primary Health Care (1) | Deprescribing (1) |
| Depression (3) | Depression 1 (1) | Dermatology (1) |
| Dermatology life Quality Index (1) | Dermic implants (1) | Design of experiments (DoE) (1) |
| Design of experiments. (1) | desirability function (1) | Desirability index. (1) |
| Desmodium gangeticum (1) | Desolvation Method (1) | Detorsion (1) |
| Deuterium (1) | device safety (1) | dexamethasone (2) |
| Dexibuprofen (1) | Dextrin (1) | DIA (1) |
| Diabetes (8) | diabetes and diabetic vascular complications (1) | Diabetes mellitus (15) |
| diabetes mellitus, (1) | Diabetes Type-II (1) | Diabetes, glucose (1) |
| diabetic dyslipidemia (1) | Diabetic nephropathy (1) | Diabetic retinopathy (1) |
| Diabetic Wound (1) | Diacerein (1) | DiaKure (1) |
| diclofenac (2) | Diclofenac SLN (1) | Diclofenac sodium (1) |
| Dicloxacillin sodium (1) | Dicots (1) | Dicyclomine (1) |
| differential scanning calorimetry (1) | diffuse transmittance (1) | Diffusion method (1) |
| Dillenia indica (2) | Dilleniaceae (1) | Diltiazem Efficacy (1) |
| Diltiazem hydrochloride (2) | Dimethylpyrimidin-derivatives (1) | Dip coating (1) |
| Diplotropis ferruginea (1) | direct compression (3) | Direct to consumer advertising (1) |
| Directly observed treatment short-course (1) | Directly observed treatment shortcourse (1) | Discharge against medical advice (DAMA) (1) |
| discharge orders (1) | DISCLE (1) | Discrepancies (1) |
| Discriminant analysis (1) | Disease (1) | Disease free survival (1) |
| disintegration (1) | disintegration time (1) | Disproportionality Analysis (1) |
| Dissolution (5) | dissolution enhancement (1) | Dissolution rate (1) |
| Diuretic (1) | Diuretic activity (2) | Diuretics (1) |
| DMAIC (1) | DMH (1) | DNA barcoding (1) |
| DNA damage (1) | DNA fragmentation (1) | docking (6) |
| Docking studies (1) | docking. (1) | Doctor (1) |
| Documentation (1) | Documentation and records (1) | Donepezil hydrochloride (1) |
| Dopamine (1) | Dosage formulation (1) | Dosage regimen (1) |
| Dose-dependent (1) | DOTS (1) | DOTS plus (1) |
| Doxorubicin (2) | Doxorubicin; FRAP assay (1) | Doxycycline (1) |
| DPP-IV (1) | DPPH Assay (1) | DPPH radical scavenging assay (1) |
| DPPH scavenging (1) | DRcaps (1) | DREEM. (1) |
| Dried blood spot. (1) | Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) | droplet size (1) |
| Drug (2) | Drug allergy tests (1) | Drug carriers (1) |
| Drug delivery (2) | Drug delivery denture (1) | Drug detailing (1) |
| drug disposal (2) | Drug drug interactions (1) | Drug Hypersensitivity (2) |
| Drug induced nephrotoxicity (1) | Drug Information and Literature Evaluation (1) | drug interaction (2) |
| Drug interaction (DI) (1) | drug interaction management (1) | Drug Interaction probability scale (1) |
| drug interactions (3) | Drug Policies (1) | Drug prescriptions (1) |
| Drug product (1) | Drug Related Problems (4) | Drug related side effects (1) |
| drug release (1) | Drug Resistance (2) | Drug risk ratio (1) |
| Drug safety (3) | Drug Safety. (1) | Drug therapy (1) |
| Drug utilization (3) | Drug utilization pattern (1) | drug utilization study (1) |
| Drug utilization. (1) | drug-drug interactions (5) | Drug-related problem (2) |
| Drug-Related Side Effects and Adverse Reactions (1) | Drug-SLS tablets. (1) | Drugedrug interaction (1) |
| Drugs (3) | Drugs and Cosmetics rules (1) | Drugs of abuse (1) |
| drug–drug gliclazide (1) | Drug–drug interaction (1) | Dry extract cinnamon (1) |
| Drying techniques (1) | DSPC (1) | Dual control release (1) |
| Dual Therapy (1) | dual-target-directed drugs (1) | Dunaliella salina (1) |
| Dynamic (1) | Dyslipidemias (1) | Dysphagia (1) |
| E-Cigarettes (1) | E-pharmacy websites (1) | e-prescribing (1) |
| E. coli (1) | E.crispa (1) | Early childhood caries (1) |
| Early-Related Complications (1) | Eastern province (2) | EC50 values (1) |
| Economic (1) | Economic burden (1) | Edaravone (1) |
| Eddy’s hot plate method. (1) | edema (1) | Edible flowers (1) |
| Editorial (24) | Education (3) | Educational excellence (1) |
| efavirenz (2) | Efficacy. (1) | EGCG (1) |
| Egfr (1) | egg albumin microspheres (1) | Elderly (1) |
| Elderly Patients (1) | Electrochemical (1) | electrolyte release (1) |
| electrolytes (1) | Electron beam radiation (1) | Electronic prescribing (1) |
| Electronic prescription (1) | Electroporation (1) | Elevated plus maze (1) |
| elevated plus maze model (1) | Elevated plus-maze (1) | Elisa (1) |
| Ellman’s assay (1) | Emblica offi cinalis (1) | Emergency contraception (1) |
| Emodin (1) | Emotional (1) | Emotional domain (1) |
| Emulgel (2) | Emulsification and Solvent Evaporation (1) | emulsion solvent diffusion method (1) |
| emulsion solvent diffusion-evaporation technique (1) | Encapsulation (1) | Encholirium spectabile (1) |
| Endocrine disruptor (1) | Endophytes (1) | Endothelial cells (1) |
| endothelial Nitric Oxide Synthase (1) | Endothelial progenitor cells (1) | Endothelium (1) |
| Endothelium. (1) | Enicostemma littorale (1) | Entire plant (1) |
| Entrapment afficiency (1) | entrapment efficiency (2) | Envenoming (1) |
| Environmental domain (1) | Environmental Factors (1) | Enzymatic hydrolysis (1) |
| Enzyme kinetics (1) | eosinophil (1) | Epicatechin (1) |
| Epigallocatechin (1) | Epigallocatechin Gallate (2) | Epigallocatechin gallate (EGCG) (1) |
| Epigenetics (1) | epilepsy (5) | Epithelial ovarian cancer (1) |
| Epithelization (1) | EQ-5D-5L (1) | EQ5D (1) |
| ER Matrix (1) | erbal drugs (1) | erice declaration (1) |
| Erythema (1) | Erythema multiforme (1) | Erythrina indica (1) |
| Erythrina variegata (1) | Erythrocyte sedimentation rate (1) | Erythroderma (1) |
| erythropoietin (2) | Escherichia coli (1) | Escitalopram oxalate (1) |
| esomeprazole (1) | Essential drugs (1) | Essential hypertension (2) |
| Essential medicine (1) | essential medicines (2) | essential oil (5) |
| essential oil composition (1) | Essential principles (1) | Esthetics Dental (1) |
| Estimated Glomerular Filtration Rate (1) | Estrogen receptor alpha (1) | Ethambutol (1) |
| Ethanol (1) | Ethanol extract (1) | ethanolic extracts (1) |
| Ethiopia (2) | ethnicity (2) | Ethnomedicine (2) |
| Ethnopharmacy (1) | Ethosomes (1) | Ethyl - 4- acetamido phenoxy acetate (1) |
| Ethyl acetate (1) | Ethyl acetate fraction (1) | ethyl cellulose (2) |
| ethylcellulose (3) | ethylene glycol (2) | Etiology (1) |
| Eucalyptus (1) | Eucalyptus hybrid (1) | Eucalyptus oil (3) |
| eudragit (2) | Eudragit RL 100 (1) | eudragit S100 (2) |
| Eudragit-L100 (1) | Eudragit® S100 (1) | Eugenol (1) |
| Euphorbia hirta leaves (1) | Eurycoma Longifolia Jack (1) | Evaluation (1) |
| EVD (1) | Ex vivo tissue entrapment (1) | ex-vivo performance (1) |
| Ex-vivo permeation (1) | Ex-vivo study (1) | Exacerbation (1) |
| Excess Alcohol Consumption (1) | Excision wound model (1) | Expectoration (1) |
| Experience (1) | experiences (1) | Experiential learning (1) |
| Experimental ischemic stroke (1) | experimental study (1) | Expired medicines (1) |
| Expiry drugs (1) | Exports (1) | Expression profile (1) |
| Extract (1) | Extrapyramidal side-effects (1) | extrinsic stains (1) |
| extrusion (1) | Eye lens (1) | Ezetimibe (2) |
| Fabaceae (2) | Facial implants (1) | Facial Pain (1) |
| Factor analysis (1) | factorial design (5) | Factors (1) |
| Factors associated with medication non-adherence (1) | Falcipain-2 (1) | Family Planning Services (1) |
| Family satisfaction (1) | family therapy (1) | famotidine (2) |
| fast disintegrating tablet (1) | Fast Disintegrating Tablets. (1) | Fast dissolving film (1) |
| Fast dissolving films (1) | Fast dissolving tablets (1) | Fasting serum insulin level (1) |
| Fat (1) | Fatty acid profile (1) | FC reagent (1) |
| FDA AERS Database (1) | FDA Approval (1) | Fenugreek (1) |
| Ferric reducing antioxidant power assay (1) | Ferritin (1) | Ferrous sulfate (1) |
| Fetal Case Report (1) | Fever (1) | Fialuridine', (1) |
| Ficus bengalensis (1) | Ficus bengalensis (Moraceae) (1) | Ficus deltoidea (1) |
| Ficus racemosa (1) | film (1) | film hydration (1) |
| Fine needle aspiration cytology (1) | First permanent molars (1) | Fixed drug eruption (1) |
| Flavone (1) | Flavonoid (3) | Flavonoid Compounds (1) |
| Flavonoid fraction (1) | flavonoids (3) | Flavoxate HCl (1) |
| FlK-1 (1) | Floating beads (1) | floating controlled drug-delivery system (1) |
| Floating Drug Delivery (1) | Floating drug delivery system (1) | floating lag time (1) |
| Floating tablets (1) | Floriculture (1) | Flue (1) |
| fluoroquinoes (1) | Fluoroquinolones (1) | Fluoxetine (1) |
| Flupritine maleate (1) | flurbiprofen (1) | Flux (2) |
| FMCG (1) | folkloric use (1) | Follow up treatment (1) |
| Food drug and cosmetic act (1) | Forced degradation (4) | Forced degradation studies (1) |
| forced swim test (1) | Formication (1) | Formulary (1) |
| Formulary. (1) | Formulation (5) | Formulation and development (1) |
| Fortification (1) | Fortified antibiotics (1) | Fourier transform infra red spectroscopic (1) |
| FPG (1) | FPGEE (1) | Fraction (1) |
| Franz Diffusion Cell (3) | FrEA5 (1) | free radical scavenger (1) |
| Free radicals. (1) | Freeze-drying (1) | Freund’s complete adjuvant (1) |
| Fructo-Oligosaccharide (FOS) (1) | Frusemide (1) | Frusemide-induced complications (1) |
| FTIR (5) | Full coverage occlusal plaques (1) | Fullerenes (1) |
| Fumes (1) | functions (1) | Fungal infections (1) |
| furosemide (1) | Future Health Care Professionals (1) | Future healthcare professionals (1) |
| G6PD deficiency (1) | GABA (1) | Galacto-Oligosaccharide (GOS) (1) |
| Galic Acid (1) | gallic acid (3) | Galphimia glauca Clav (1) |
| Gamma irradiation (1) | Gamma scintigraphy (1) | Gangrenous (1) |
| Ganoderma lucidum (1) | Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) | Garcinia daedalanthera extract (1) |
| Garcinia imberti (1) | Garcinia imberti bourd (1) | Garcinia indica (1) |
| Garcinia latissima (1) | gaseous contact (1) | gastric treatment (1) |
| Gastric ulcer (1) | Gastro-retentive drug delivery system (1) | gastroprotection (2) |
| gastroretentive (1) | gastroretentive drug delivery system (1) | Gatot Soebroto hospital. (1) |
| GC-MS (1) | GC-MS analysis (2) | GC-MS. (1) |
| GDP (1) | Gelatin (1) | Gelling Capacity. (1) |
| Gels (1) | Gemcitabine HCl (GCH) (1) | gemfibrozil (1) |
| Gender (1) | Gender and HIV. (1) | Gene expression (1) |
| Gene expressions (1) | Gene modification (1) | Gene silencing (1) |
| General medicine (1) | Generic (2) | generic drugs (2) |
| Generic Medicine (1) | Generic medicines (2) | Generic name. (1) |
| Generic substitution (1) | Generics (1) | Genetic polymorphisms (1) |
| genetic Signature (1) | Genotoxin (1) | Genotype frequency (1) |
| Gentamicin (5) | gentamicin sulfate (2) | Geriatrics (3) |
| Gewald’s reaction (1) | GFAP (1) | Gibb’s reagent (1) |
| Gina criteria (1) | Ginger (1) | Gingival hyperplasia (1) |
| Gingival hypertrophy (1) | gingival pocket (1) | Gingival recession (1) |
| Gingival thickness (1) | Gladiolus segetum (1) | glibenclamide (5) |
| gliclazide (2) | Glidescore (1) | Glimepiride (2) |
| glimepride (1) | Glipizide (3) | glitazars (1) |
| Global education (1) | Global publications (2) | Glomerulonephritis (1) |
| Glucagon (1) | Glucocorticoids (1) | Glucosamine (1) |
| Glucosamine sulphate (1) | Glucose (1) | Glucose metabolism (1) |
| glucose tolerance test (1) | glutathione (1) | Glycemic Control (1) |
| Glycerin (1) | Glycerine (1) | Glyceryl monostearate (1) |
| Glycine max (1) | Glycosylated hemoglobin (HbA1c) (1) | Glycosylated hemoglobin A1c (1) |
| Gnetum gnemon (2) | Goal orientation (1) | Goldenhar syndrome (1) |
| good manufacturing practices (1) | Gotu kola leaves extract (1) | Government sector (1) |
| GPx (1) | Graft Rejection (1) | Graft Survival (1) |
| Grafting (1) | Grafts (1) | Gram negative (1) |
| Gram positive (1) | Gram-Negative Organisms (1) | Gram-Positive Organisms (1) |
| Grape seed extract (1) | Grape seed oil (1) | Grapes seed extract (1) |
| Gravimetry (1) | Grazing angle X-ray diffraction (1) | Green tea (1) |
| Green Tea Leaves Extract (2) | Grip strengthening test (1) | Griseofulvin (1) |
| GSH (2) | guanyl cyclase stimulator (1) | Guest Editorial (1) |
| Guidelines (1) | Guinea pig (1) | Gulf cooperation council (1) |
| Gum and fat fractions (1) | Gum arab (1) | Gymnema Sylvestre (2) |
| Gynura procumbens (1) | GYTS (1) | H+ (1) |
| H-460 (1) | H2 Receptor Antagonist (1) | H2O2 (1) |
| HAART (1) | Habits (1) | Haematological (1) |
| Haemoglobin (1) | Haemolysis (1) | Haemolytic ratio. (1) |
| Hair dye. (1) | Hair Growth Activity (1) | Hair Tonic (1) |
| Hajj (1) | haloperidol (2) | Hand and Foot Syndrome (1) |
| hardness (1) | Haritaki (1) | harmacotherapy-based problems (1) |
| Harmonization (2) | Hartwigs Severity Assesment Scale (1) | Haryana (1) |
| Hazardous drugs (1) | HbA1C (2) | HBV (1) |
| HCT: Hydrocholrothiazide. (1) | HDAC4 (1) | HDAC7 (1) |
| head twitch (1) | Health benefits (1) | Health Care Coordination and Monitoring (1) |
| Health Care Costs (1) | Health care profession (1) | health care professionals (1) |
| health care students (2) | Health care. (1) | Health Education (1) |
| Health Expenditures (1) | Health for All (1) | Health Hazard (1) |
| Health informatics (1) | Health Information Technology (1) | Health Knowledge (1) |
| Health problems (1) | Health Professionals (1) | Health Professions Students (1) |
| Health related quality of life (1) | Health risks (1) | Health Services Accessibility (1) |
| Health Status Indicators (1) | Healthcare (4) | healthcare communication (1) |
| Healthcare Delivery (1) | healthcare expenditure (1) | Healthcare Professionals (1) |
| healthcare providers (1) | Healthy volunteers (1) | heart failure (3) |
| Heart failure clinics (1) | Heat-shock (1) | Hematological parameters (1) |
| hematological toxicity (1) | Hematology (2) | Hematoma (1) |
| Hematopoietic progenitors (1) | Hemodialysis (2) | Hemoglobin (1) |
| Heparin (1) | hepatic impairment (2) | Hepatic marker (1) |
| Hepatitis (1) | Hepatitis B (1) | Hepatitis B virus core protein (1) |
| Hepatocellular (1) | Hepatocurative (1) | hepatoprotective (3) |
| hepatoprotective activity (3) | Hepatotoxicity (1) | HER1 (1) |
| HER2 (1) | HER3 (1) | HER4 (1) |
| Herbal active ingredients (1) | Herbal drugs (1) | Herbal medications (1) |
| Herbal medicine (2) | herbal medicines (1) | Herbal therapy (1) |
| Herbaldb (1) | HET-CAM (1) | Heterocyclic compound (1) |
| Heterotopic Pregnancy (1) | Hex (1) | Hexane (1) |
| Hibiscus cannabinus Linn. (1) | Hibiscus rosa. (1) | High fat diet (2) |
| High Fat Diet Model (1) | High impact resin (1) | high performance liquid chromatography (1) |
| high performance thin layer chromatography (1) | High-density lipoprotein cholesterol (1) | High-fat diet (1) |
| high-performance liquid chromatography (2) | High-throughput screening (1) | Higher education (1) |
| highly active antiretroviral therapy (1) | Highly Cited Papers (1) | Himatanthus drasticus (1) |
| Hip Arthroplasty (1) | Hirsutism (2) | Histocompatibility. (1) |
| Histological studies. (1) | Histopathological studies (1) | Histopathology (2) |
| HIV (2) | HIV associated dementia. (1) | HIV-1 RT (1) |
| HIV-associated neurocognitive disorder (1) | HIV/AIDS Patients (1) | HL-60 and K-562 (1) |
| HLA (1) | HMG-CoA Reductase (1) | Homalium zeylanicum (1) |
| Homeopathic medicines (1) | Homeopathy (1) | homology modeling (1) |
| Honey (1) | Honeycomb (1) | Hordeum vulgare (1) |
| Hordeum vulgare hull (1) | Horticulture (1) | Hospital pharmacy (2) |
| hospitalized children (1) | hospitalized patients (1) | Hospitals (1) |
| host (1) | Host-guest interactions (1) | hot plate (1) |
| HP-ß Cyclodextrin complexes (1) | HPLC (9) | HPLC (High Performance Liquid Chromatography) Ornidazole (1) |
| HPLC method validation (1) | HPLC. (1) | HPMC (1) |
| HPMC capsules (1) | HPMC K100M (2) | HPMC K4M (1) |
| HPTLC (7) | HPTLC Fingerprinting (1) | HQLQ (1) |
| HRQoL (3) | HSV-1 (1) | Human breast cancer cells (1) |
| Human breast cancer MCF -7 cells (1) | human immunodeficiency virus (3) | human immunodeÞ ciency virus (1) |
| Human Papillomavirus (1) | Human plasma (2) | human plasma level (1) |
| Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) | Humanitarian device exemption. (1) | Hyaluronic acid (1) |
| Hydnocarpus Pentandra (1) | Hydralazine hydrochloride (1) | Hydroalcoholic (1) |
| hydrochlorothiazide (2) | Hydrochlorthiazide (1) | hydrogel (2) |
| Hydrogels (1) | hydrogen sulfide (1) | hydrogenated castor oil (1) |
| Hydrophilic drugs (1) | Hydrophillic sealants (1) | Hydrophobic sealants (1) |
| Hydrotrophy (1) | hydroxy propyl methyl cellulose (1) | Hydroxyapatite (1) |
| Hydroxyl radical (1) | Hydroxyproline (1) | hydroxypropyl cellulose (1) |
| hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose (2) | Hydroxypropyl methylcellulose E15 (1) |
| Hydroxypropyl-β- cyclodextrin (1) | Hydroxypropylmethyl cellulose (1) | Hydroxypropylmethylcellulose (1) |
| Hyperactive orofacial musculature (1) | Hypercholesterolemia (1) | Hypercholestremia (1) |
| Hyperglycemia (1) | Hyperglycemic (3) | Hyperglycemic mice (1) |
| Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) | hyperoxaluria (1) |
| Hypersensitivity (1) | Hypersensitivity reaction (1) | hypertension (9) |
| Hypertension( HTN) (1) | Hypertensive’s (1) | Hyperthyroidism (1) |
| hypertriglyceridemia (2) | Hypertrophy (1) | Hyperzincuria (1) |
| Hyphenated system (1) | hypoglycemic (1) | Hypoglycemic activity (1) |
| hypolipidemic (1) | Hypomineralization (1) | Hypothyroidism (1) |
| Hypozincaemia (1) | IBD (1) | IBD - Inflammatory Bowel Disease (1) |
| IBS (1) | IC50 (2) | ICH (2) |
| ICH guidelines (3) | ICP22 (US1) gene (1) | IL-17 (1) |
| IL-6 (2) | IL-MAE (2) | Illicit Drugs (1) |
| Illiterate (1) | Iloperidone (1) | image analysis (1) |
| imidazole (1) | Immediate release layer and Bioavailability (1) | Immune response (1) |
| Immune suppression (1) | immunocytochemistry (1) | Immunoinformatics (1) |
| Immunological response (1) | Immunomodulatory (2) | Immunomodulatory effect (1) |
| Impacted (1) | Improving (1) | Impurity (1) |
| Impurity related substances (1) | In silico (2) | in situ gelation (1) |
| in vitro (4) | In vitro kinetics (1) | In vitro penetration lotion (1) |
| In vitro penetration test (1) | In vitro Penetration Test. (1) | In vitro release (1) |
| In vitro–In vivo (1) | in vivo (1) | In vivo kinetics (1) |
| In-patien (1) | In-situ gel (1) | in-vitro dissolution study (1) |
| In-vitro skin permeation (1) | Inappropriateness (1) | Inclusion complex (1) |
| inclusion complexes (2) | indexed cost (1) | India (8) |
| India. (1) | Indian context (1) | Indian publications (1) |
| Indian Traditional medicine (1) | Indigenous (1) | Indion 234 (2) |
| Indion resin (1) | indomethacin (2) | Indonesia (3) |
| Indonesian Herbal Database. (1) | Indonesian National Health Insurance (1) | Industry (2) |
| Inequality (1) | infarct size (1) | Infection prevention (1) |
| infective endocarditis (1) | infertility (1) | Infit and outfit indices (1) |
| inflammation (4) | inflammatory bowel disease (2) | Inflorescence (1) |
| Information need (1) | Information system (1) | Information Technology Officers (1) |
| Information tool (1) | Inhibitor MDM2 (1) | Inhibitory activity (1) |
| Injectable (1) | innovation ecosystems (1) | inorganic salts. (1) |
| Inquiry learning (1) | INR (1) | inß ammation (2) |
| inß ammatory bowel diseases (1) | Insilico anticancer screening (1) | insulin (6) |
| Insulin receptor (1) | Insulin regimen (1) | insulin resistance (1) |
| Insulin resistance. (1) | insulin use in primary care (1) | Insulinophobia (1) |
| Integrase inhibitor (1) | Integrated Courses (1) | integrated economic analysis (1) |
| Intellectual Property l (1) | Intellectual property rights (1) | intelligent tutoring (1) |
| Intensive care unit (1) | Intensive Care Unit (ICU) (1) | Intensive Monitoring (1) |
| interaction (2) | interferon (1) | interleukins (1) |
| International Collaboration (1) | International HIV dementia scale (IHDS) (1) | international organization (1) |
| international organizations (1) | international trade (1) | Internet (1) |
| Internet pharmacy (1) | Interocclusal device (1) | interpretation (1) |
| Interventional tool (1) | Interventions (1) | Intervertebral disc C4/5 and C5/6 (1) |
| Intoxications (1) | Intracanal medicament (1) | Intranasal delivery (1) |
| intraocular presuure (1) | Intrauterine Pregnancy (1) | Intravenous (1) |
| Intravenous immunoglobulin (1) | inventory index (1) | inventory management (3) |
| Investigation (1) | investigators (1) | Invited Article (2) |
| Ion Gelation Method (1) | ion pair complex (1) | Ionic gelation (1) |
| Ionic liquid (3) | Ionic liquid- based microwave-assisted extraction (1) | ionic liquid-based microwave-assisted extraction (1) |
| Ionizing radiation (1) | ionotropic gelation (1) | iontophoresis (2) |
| Ipsilateral symptoms (1) | Iraq (1) | Iridoid glycoside (1) |
| iron chelation therapy (1) | Irrational (1) | Irrigation (1) |
| Irvingia gabonensis (1) | isatin (3) | ischemia (1) |
| ischemia-reperfusion injury (1) | Ischemic (1) | ischemic heart disease (1) |
| ISO (1) | Isolated aortic rings (1) | isoniazid (3) |
| isonicotinohydrazide (1) | Isoprinosine (2) | Isopropyl myristate (1) |
| isoproterenol (1) | isoxazoline (1) | itopride HCl (1) |
| JNC 8 Guidelines. (1) | Journal (1) | Jurkat (1) |
| K+-ATPase β subunit (1) | K+ATP channel (1) | K-CAPS (1) |
| K562 (1) | Kaffir lime (1) | Kajjali (1) |
| Kakoli (1) | Kalanchoe Pinnata (1) | KAP (2) |
| KAP Questionnaire (1) | KAP study (1) | Kappa Concordant value (1) |
| Kappa. (1) | Karachi (2) | Kathakakhadiradi kashyam (1) |
| Kati chakrasana (1) | Kernel powder (1) | Ketamine (1) |
| Ketoprofen (1) | Ketorolac (1) | Ketorolac salt (1) |
| Key words: 5-FU (1) | Key words: Esomeprazole (1) | kidney (2) |
| Kidney Transplantation (1) | kinetic drug release (1) | Kinetic Modelling (1) |
| KMnO4 (1) | kneading method (1) | kneading technique (1) |
| knowledge (19) | Kojic acid (1) | Kumar’s score (1) |
| L-arginine (1) | L-Thyroxine (1) | L. acidophilus (1) |
| labeling (1) | Laboratory findings. (1) | Lactobacilli (2) |
| Lactobacillus (1) | Lag period (1) | Lagenaria siceraria (1) |
| Lantana camara (1) | Lantana montevidensis (1) | Larvacidal (1) |
| Larvicidal (1) | Laurence-Moon-Bardet-Biedl Syndrome (1) | Lawsone methyl ether (1) |
| LC-MS (1) | LC-MS/MS (1) | LC/MS/MS (1) |
| LC50 (1) | LCMS/MS (1) | LC–MS/MS (1) |
| LDL-C (1) | Leaf (1) | Learning (1) |
| Learning process (1) | leaves (4) | Leftover medicines, (1) |
| Leg Length (1) | Leptin (1) | Letter to Editor (4) |
| Letter to the Editor (3) | Letters to the Editor (6) | Leucaena leucocephala (1) |
| Leucas lavandulaefolia (1) | Levocetirizine (1) | Levodopa (1) |
| Levofloxacin (1) | Lexicomp (1) | Lichen planus (1) |
| Licofelone (1) | Ligand-based drug design (1) | Lightening (1) |
| Limb Length (1) | Limbs (1) | lime fruit (1) |
| Linagliptin (1) | Lindernia ciliata (1) | Linezolid (1) |
| Linoleic acid (1) | lipid matrix (1) | lipid metabolism (2) |
| Lipid Microparticles (1) | lipid microspheres (1) | Lipid nanocrystals (1) |
| Lipid peroxidation (3) | lipid peroxides (1) | lipid profile (1) |
| Lipid profile membrane bound enzymes (1) | lipids (1) | lipoic acid (1) |
| liposome (1) | Lippia (1) | Liquid chromatography (1) |
| lithium toxicity (1) | Live-well™ (1) | liver function (2) |
| Liver necrosis (1) | Liver tonic (1) | Liver Transplantation (1) |
| Local drug delivery (1) | Lockdown (1) | locomotor activity (1) |
| Long term memory (1) | Low-density lipoprotein cholesterol (1) | Lozenges (1) |
| LRTIs (1) | Luffa echinata (1) | Lumbar Spinal Stenosis (1) |
| Luminesce (1) | Lung (1) | Lung cancer (3) |
| Lupenoic acid (1) | Lupus (1) | Lycatab C (1) |
| Lympadenopathy (1) | lymphadenitis (1) | Lymphoma (1) |
| Lysozyme (1) | M. tuberculosis H37Rv (1) | Maceration (1) |
| Macromicroscopy study (1) | Macrophage (1) | Macrophage cell line (1) |
| Mahkoside A (1) | Major Contributed Organizations (1) | Malaysia (5) |
| Malaysia. (1) | Malaysian. (1) | Male (1) |
| Male fertility (1) | Maleic Acid (1) | Malignant lesions (1) |
| Malignant transformation (1) | Malocclusion (1) | malondialdehyde (2) |
| Maltodextrin (2) | Mammary carcinoma (1) | Mandibular hypoplasia (1) |
| Mangiferin (1) | Mangosteen Peels (1) | manidipine dihydrochloride (1) |
| Mannich base (1) | Mannich Bases (1) | Marine fungi compounds (1) |
| Marketed Brands (1) | Mast cell (1) | Maternal Care. (1) |
| Mathematical modeling (1) | matrix (1) | Matrix Tablet (1) |
| matrix tablets (3) | Maxillofacial complications (1) | MCF-7 (1) |
| MDA (2) | MDR-TB (2) | mean age (1) |
| Mechanism (1) | mechanisms (1) | Meclizine HCl (1) |
| Medical (1) | Medical and non-medical (1) | medical costs (1) |
| Medical device (1) | Medical device recalls (1) | medical errors (1) |
| Medical informatics (1) | Medical Inpatients (1) | Medical practitioner (1) |
| Medical Representative (1) | Medical Respresntative (1) | Medical sales representative (1) |
| Medical students (2) | medication adherence (6) | medication adherence behaviour (1) |
| medication error (2) | Medication errors (2) | Medication non-adherence (1) |
| Medication reconciliation (1) | Medication regimen complexity (1) | medication safety (1) |
| Medication taking (1) | Medication understanding (1) | medication-/drug-related problem (MRP/DRP) (1) |
| Medicinal ornamental plants (1) | Medicinal plant (1) | Medicinal plants (4) |
| Medicine (2) | Medicine consumers (1) | Medicine disposal (1) |
| medicine-use practices (1) | Medicines storage (1) | Medicines wastage (1) |
| Mediterranean diet (1) | Melanesia (1) | Melastoma malabathricum (1) |
| Melinjo (2) | Meloxicam (1) | Memory (2) |
| Memory and learning. (1) | Men (1) | Men who have Sex with Men (1) |
| Menaquinone-4 (1) | Menstrual cycle (1) | Mental Disorders (1) |
| Mental health (2) | Mental health challenges (1) | Mental health services. (1) |
| Mentha arvensis (1) | Menthol oil (1) | mesalamine (1) |
| Metabolic ratio (1) | Metabolic syndrome (1) | Metabolism (1) |
| Metabolite profiling (2) | Metabomics (1) | metagenomic (1) |
| metformin (8) | metformin hydrochloride (1) | Methanol (1) |
| methanolic extract (1) | methocel (2) | method development (5) |
| Method optimization (1) | method validation (4) | Method validation Valsartan (1) |
| Methotrexate (1) | methyl orange (1) | methyl-b cyclodextrin (1) |
| metoprolol tartarate (1) | MetS (1) | Mevalonate (1) |
| MHCs (1) | Micelle (1) | Micro emulsion (2) |
| Micro particles. (1) | Micro-emulsion (1) | microbial contamination (1) |
| Microbiological (1) | Microbroth dilution (1) | Microcapsules (1) |
| microcrystalline cellulose (5) | microdilution (1) | Microdosing (1) |
| Microemulsion (1) | Microencapsules (1) | microneedles (1) |
| Micronucleus assay (1) | microparticles (1) | microsphere (1) |
| Microsphere Phytosome (1) | microspheres (6) | microtriches (1) |
| Microwave assisted extraction (1) | Microwave-Assisted Extraction (2) | miglitol (1) |
| Migraine (3) | migraine management, (1) | Migrant labor (1) |
| Mild neurocognitive disorder (1) | Milk (1) | Milnacipran (1) |
| Mimosa pudica (1) | Mineral trioxide aggregate (1) | minimal inhibitory dose (1) |
| Minimum Inhibitory Concentration (MIC) (1) | mismatches (1) | mitochondria (1) |
| Mix mode (1) | MLR (1) | MMAS-8 - Modified Morisky Adherence Scale-8 (1) |
| Modafinil (1) | Modeling (1) | modern medicine (1) |
| modified melt dispersion technique (1) | Modified Starches (1) | MODY (1) |
| Mol inspiration (1) | Molar Incisor (1) | Molecular characterization (1) |
| Molecular docking (10) | molecular docking and anti cancer activity. (1) | Molecular Docking. (1) |
| Molecular Dynamic (1) | Molecular dynamics (3) | Molecular Dynamics Simulations (1) |
| Molecular Imprinted Polymer (1) | Molecular mimicry (1) | Molegro Virtual Docker 6.0 (1) |
| Momordica charantia (1) | Momordicin II Natural Products (1) | monoamine oxidase B (1) |
| Monocots (1) | Monophyletic (1) | montelukast (2) |
| montelukast sodium (1) | Montelukast, (1) | moraceae (1) |
| Morbidity (1) | Morin and validation (1) | Moringa oleifera (3) |
| Moringa oleifera. (1) | Morisky medication adherence questionnaire (1) | Morocco (2) |
| Mortality (4) | Morus alba (2) | Mosquito repellent (1) |
| Mouth Dissolving Tablets (1) | mouth-dissolving film, (1) | MPO activity (1) |
| MPTP (1) | MRI Contrast agents (1) | MTT Assay (2) |
| MTT method (1) | MUC2 (1) | MUC6 (1) |
| Mucoadhesive (1) | Mucoadhesive agent (1) | mucoadhesive formulation (1) |
| Mucoadhesive Oral In situ gel (1) | mucoadhesives (1) | mucodhesive (1) |
| Mulberry (1) | multi granules (1) | Multi Organ Failure (1) |
| multidrug resistant pathogens (1) | Multikinase Inhibitor (1) | multiparticulates (1) |
| multiparticulates dosage form (1) | Multiple myeloma (1) | Multiple Organ Dysfunction Syndromes (MODS) (1) |
| Multiple Organ Failure (1) | multiple regression (1) | multiple regression analysis (1) |
| Multisystem inflammatory syndrome-children (1) | Multitargeted drug (1) | Murraya koenigii L.Sprengel S.mutans (1) |
| Muscle tmd (1) | Mycobacterium tuberculosis. (1) | Mycophenolate mofetil (2) |
| Mycophenolic acid (1) | Myeloperoxidase (1) | myocardial infarction (2) |
| Myomectomy. (1) | Myrica esculenta (1) | Myristicin (1) |
| Myrobalan (1) | N-aminoimidazoles (1) | N-napthyl ethylene diamine dihydrochloride (1) |
| Na+/K+-Atpase (1) | NABP (1) | NACO. (1) |
| Nadi shuddhi pranayama (1) | Naftopidil (1) | Naltrexone (1) |
| nano size (1) | Nanocellulose (1) | Nanocrystals (1) |
| Nanoemulsion (1) | Nanofibers (1) | Nanoformulation (2) |
| nanoformulations (1) | Nanonization. (1) | Nanopacticle (1) |
| Nanoparticle (3) | Nanoparticles (12) | Nanosuspension (1) |
| Nanosuspension tablets (1) | Nanosuspensions (1) | Naphthoquinone derivative (1) |
| NAPLEX (1) | naproxen (1) | Naranjo (1) |
| Naranjo algorithm (2) | Naranjo algorithm. (1) | Naranjo Causality Assessment (1) |
| Naranjo Probability Scale (1) | Naranjo’s ADR probability scale (1) | Narikel Lavan (1) |
| Narrow therapeutic index drugs (1) | Nasal delivery (1) | Nasal gel (1) |
| Nateglinide (1) | National Fomulary (1) | National Formulary (2) |
| National Health and Morbidity Surveys (1) | National policy (1) | National Policy of Pharmaceutical Assistance (1) |
| National Public Health Programs (1) | Natural (1) | natural compounds (3) |
| Natural deep eutectic solvent (1) | Natural Polymers (1) | natural products (5) |
| NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) | Nebivolol (2) | nebivolol hydrochloride (1) |
| Necrosis. (1) | need assessment (1) | Neoplasm (1) |
| Nepal (1) | Nephropathy (1) | Nephroprotective (3) |
| Nephrotic syndrome (1) | Nephrotoxicity (1) | Nerium indicum (1) |
| neuropathy (1) | Neuroprotection (1) | Neuroprotective (1) |
| Neurosurgical (1) | neutropenia (1) | nevirapine (1) |
| new molecule (1) | Newborns (1) | Nicorandil (1) |
| Nicotine (1) | Nicotine dependence (1) | Nifedipine. (1) |
| Nigeria. (1) | nigrostriatal pathway (1) | Nil (13) |
| Nill (19) | Nimesulide (1) | niosome (1) |
| Niosomes (1) | Nitric acid (1) | Nitric oxide (5) |
| Nitrogen starvation (1) | Nitroglycerin (1) | NK cell (1) |
| NMDA (1) | NMDA receptors (1) | Noccik Kudinir (1) |
| Nodular skin lesions (1) | Non-linear (1) | non-prescription medicine use (1) |
| Non-steroid anti-inflammatory (1) | Non-steroidal anti-inflammatory drugs (1) | Non-surgical endodontic therapy. (1) |
| nonamers. (1) | noncommunicable disease (1) | noncompliance (1) |
| Nonionic surfactants (1) | Nonomuraea longicatena (1) | nootropic (1) |
| Norfloxacin (1) | Normoglycemic rats (1) | northeast India (1) |
| Nose to brain delivery (1) | Nosocomial infections (1) | Nothopanax scutellarium (1) |
| Novel delivery (1) | Novel drug delivery system (1) | NSAIDs (3) |
| Nuclear medicine (1) | nuclear pharmacy (1) | Nucleo CMP (1) |
| Nude mice (1) | Nutmeg oil (1) | Nutraceuticals (1) |
| Nutrient starvation (1) | Nutrition (1) | Nystagmus Phenytoin toxicity (1) |
| O-Phenylene diamine (1) | Obesity (4) | Occupational health (1) |
| Ocimum gratissimum (1) | Odontopediatric (1) | Odorant binding Protein (1) |
| Off-label (1) | offending drugs (1) | Okra Mucilage (1) |
| Olmesartan (1) | olmesartan medoxomil (1) | Omega-6 fatty acid (1) |
| Omeprazole. (1) | Omics (1) | Oncology. (1) |
| Oncopharmacists (1) | ondansetron (3) | ondansetron hydrochloride (1) |
| Online health screening (1) | Online pharmacies (1) | OPD – Outpatient Department. (1) |
| open field (1) | Open field task (1) | Ophthalmic (1) |
| ophthalmic delivery (1) | ophthalmic inserts (1) | Opinion (1) |
| Opportunities (1) | Opportunity (1) | Optimal stress (1) |
| optimization (9) | Oral bacteria (1) | Oral cancer (3) |
| Oral diagnosis (1) | Oral disease (1) | Oral diseases (1) |
| oral disintegrating tablets (1) | Oral glucose tolerance (1) | oral glucose tolerance test (3) |
| Oral Health (1) | oral hygiene (1) | Oral hypoglycemic agents (1) |
| Oral hypoglycemic drugs (1) | oral insulin (1) | Oral manifestations (1) |
| Oral Medicine (1) | Oral Rehabilitation (1) | Oral route (1) |
| Oral Surgery (2) | Orally disintegrating tablets (1) | Organ Toxicities (1) |
| organic acids (1) | organogel (1) | Organophosphate (1) |
| ORIF (1) | Origanum vulgare (1) | Original Article (3) |
| Originator. (1) | Orlistat (2) | orodispersible tablet (1) |
| orodispersible tablets (2) | Oscillopsia (1) | Osmotic pump (1) |
| Osseointegration (1) | Osteoarthritis (3) | Osteoblast (3) |
| Osteoclast (2) | Osteoporosis (1) | OTC switch (1) |
| Otomycosis (2) | Outcome therapy (1) | Outdoor patients (1) |
| Outpatient Pharmacy (1) | Outpatient Psychiatry (1) | Outpatients (1) |
| ovalbumin (1) | Ovarian (1) | Ovarian Cyst (1) |
| Over the counter (1) | Over-the-counter (1) | Overweight (1) |
| OVX (1) | Oxalic acid (1) | oxazepinone (1) |
| oxcarbazepine (1) | Oxidation (1) | oxidative damage (1) |
| oxidative stress (6) | Oxyresveratrol (2) | oxytetracycline (1) |
| P-dimethylaminobenzaldeyde (1) | P-drug. (1) | P-drugs (1) |
| P-glycoprotein (1) | P. dulce (Fabaceae) (1) | p21SNFT (1) |
| p53 tumor suppressor gene (1) | Package insert (1) | Paediatric (2) |
| Paediatrics (1) | Pain (2) | Pain scale (1) |
| Pain. (1) | Painkiller (1) | pair wise procedures (1) |
| Pakistan (2) | Pakistan. (4) | Paliperidone palmitate (1) |
| Pancreatitis. (1) | Pantoprazole (1) | papain (2) |
| Papain. (1) | PAR-2 receptor (1) | para-diaminobenzaldehyde (1) |
| paracetamol (5) | Paracetamol. (2) | Paresis (1) |
| Parkinson’s disease (2) | Partial coverage occlusal plaques (1) | partial least square (1) |
| particle size analysis (1) | PASS (1) | passive avoidance learning (1) |
| Patch (1) | patents (4) | Pathological response (1) |
| Patient (2) | Patient adherence. (1) | Patient Care (1) |
| patient counseling (2) | Patient counseling and Patient information leaflet (1) | patient education (2) |
| Patient health questionnaire (PHQ) (1) | Patient initiated adverse drug reporting (1) | Patient Safety (2) |
| Patient satisfaction (1) | Patient Satisfaction Questionnaire (1) | Patient Survival (1) |
| patient-physician communication (1) | Patient-safety (1) | patients (4) |
| Patients. (1) | paw edema (1) | Paw edema. (1) |
| Paw volume (1) | PE 18:0/18:0-PEG 2000 (1) | Pectin (1) |
| pedagogy (1) | Pediatric (3) | Pediatric cancer (1) |
| Pediatric Dentistry (1) | Pediatrics (1) | Pediculosis (1) |
| Pegagan extract (1) | PEGylation (1) | Pemphigus vulgaris (1) |
| Penang (1) | penetration (3) | penetration enhancer (1) |
| penetration pressure (1) | penicillamine (1) | Penicillins (1) |
| pentylenetetrazole (1) | PEO (1) | Peperomia pellucida (L) Kunth (1) |
| Peperomia pellucida (L.) Kunth (3) | Peppas and Higuchi’s equations (1) | Peppermint oil (1) |
| Peptic Ulcer. (1) | peptide vaccine (1) | Peptidoglycan (1) |
| percentage healing of wound area (1) | Percentage wound closure (1) | perception (9) |
| Periauricular tags. (1) | pericyclic fiber (1) | Periodontal disease (1) |
| periodontal diseases (1) | Periodontal dressing (1) | periodontal pocket (1) |
| Peripheral Neuropathy (1) | Permanent (1) | Permeation (5) |
| Permeation enhancer (1) | Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) | Persistent ulcer (1) |
| Personal care products (2) | Persons and items reliability (1) | pH dependent approach (1) |
| pH independence (1) | pH-sensitive (1) | Phagocytosis (1) |
| Phaleria marcocarpha (1) | Pharm. D. Integrated (1) | Pharm. D. Post Baccalaureate. (1) |
| pharma counseling (1) | pharmaceutical (1) | pharmaceutical advertisements (1) |
| Pharmaceutical care (2) | Pharmaceutical Care service (1) | pharmaceutical care. (1) |
| pharmaceutical formulations (1) | Pharmaceutical Industry (1) | Pharmaceutical Marketing (1) |
| Pharmaceutical Services (2) | Pharmaceutical-Care (1) | Pharmaceutical-industries (1) |
| Pharmaceutics (1) | Pharmacist (5) | Pharmacist intervention (1) |
| Pharmacist intervention. (1) | pharmacist role in public health (1) | Pharmacists (2) |
| pharmacists India (1) | Pharmaco epidemiology (1) | Pharmacodynamic (3) |
| Pharmacodynamic activity (1) | pharmacodynamics (2) | Pharmacoepidemiology (1) |
| Pharmacogenetics (1) | Pharmacogenomics (1) | Pharmacognostic (1) |
| pharmacognostic standardization (1) | pharmacognostical (1) | Pharmacognosy (1) |
| pharmacognosy study (1) | Pharmacokinetic (7) | Pharmacokinetic interactions. (1) |
| pharmacokinetics (10) | Pharmacokinetics. (2) | Pharmacological properties (1) |
| Pharmacophore (3) | Pharmacosomes (1) | Pharmacotherapy (2) |
| Pharmacovigilance (20) | Pharmacovigilance Programme of India (1) | Pharmacovigilance. (1) |
| Pharmacovigilante’s (1) | Pharmacovigillance (1) | pharmacy (6) |
| pharmacy curriculum (2) | Pharmacy education (1) | Pharmacy Enforcement Division (1) |
| Pharmacy informatics (1) | Pharmacy intervention (1) | Pharmacy practice (1) |
| Pharmacy services (1) | Pharmacy store (1) | Pharmacy student (1) |
| Pharmacy students (2) | Phase diagrams (1) | Phase I studies (1) |
| Phase rule (1) | phase solubility (1) | phase solubility profile (1) |
| Phenobarbitone (1) | Phenolic (1) | phenolic compounds (2) |
| Phenolic content (1) | phenolics (1) | phenols (1) |
| Phenothiazine (1) | Phenytoin (5) | Phenytoin cold cream (1) |
| Phenytoin Toxicity (1) | Pheritima posthuma (1) | Phleboliths (1) |
| Phoenix dactylifera (1) | Phospholipid E80 (1) | Phosphorylase kinase (1) |
| Photoprotection. (2) | Phthalates (1) | Phyllanthus emblica, (1) |
| Phyllanthus reticulatus (1) | Phylogenetic tree (1) | Phylogeny (1) |
| Physical activity (1) | Physical fitness (1) | Physical stability (1) |
| Physichochemical Characterization (1) | Physicians (5) | Physicochemical (1) |
| physicochemical evaluation (1) | physicochemical properties (1) | Physicochemical Tests (1) |
| physiochemical descriptor (1) | Physiological role (1) | Phytochemical (2) |
| phytochemical prospection (1) | Phytochemical screening (2) | Phytochemicals (1) |
| Phytoconstituents (1) | Phytomolecule (1) | Phytopharmaceutical drug (1) |
| Phytosome (1) | picrotoxin (1) | pictograms (1) |
| Pilgrims (1) | PIM (1) | Pinus merkusii (1) |
| pioglitazone (1) | piperazine citrate (1) | Piperidino thiophene (1) |
| Piperine (2) | Piroxicam (2) | Pits and Fissures (1) |
| Pixel intensity. (1) | Placements (1) | Plackett-Burman (1) |
| Plackett-Burman design (1) | plant extracts (1) | plasma (3) |
| Plasma concentration (1) | plasma concentrations (1) | Plasma creatinine (1) |
| Plasma insulin (1) | Plasma urea (1) | plasma-brain correlation (1) |
| Plasma. (1) | Plasmodium falciparum 3D7 (1) | Plasmodium falciparum. (1) |
| Platelet aggregation. (1) | Platelet concentrates (1) | Platelet rich fibrin membrane. (1) |
| Pleiotropic effects (1) | PLGA (1) | PLS (1) |
| PLSR (1) | Pluronic (1) | Pluronic F 127 (1) |
| PM6 (1) | PM7 (1) | Pneumonia (2) |
| POGIL (1) | Point-measure correlation coefficients (1) | Poison (2) |
| Poisoning pattern (1) | Polarography (1) | Poloxamer 188 (1) |
| Poloxamer 407 (2) | Poloxamer 407. (1) | poly (lactic-co-glycolic acid) (1) |
| Poly herbal (1) | poly(ε-caprolactone) (1) | Poly-herbal (1) |
| polycaprolactone (1) | Polycystic Ovary Syndrome (1) | Polyelectrolyte complex (PEC) (1) |
| PolyElectrolytecomplex (1) | Polyethylene glycol (1) | Polyherbal (1) |
| polyherbal formulation (3) | Polymer (1) | Polymeric nanoparticles (3) |
| Polymorphism (1) | polypharmacy (8) | polypharmacy in diabetes mellitus. (1) |
| polyphenols (1) | Polysaccharide (1) | polyvinyl alcohol (2) |
| polyvinyl pyrrolidone (1) | Polyvinylpyrrolidone (1) | Polyvynil pyrrolidone (1) |
| Pomalidomide (1) | PON1 mRNA (1) | porosity (1) |
| Port-A Catheter. (1) | Portfolio (1) | Positive and Negative stressors (1) |
| Positive coping strategies. (1) | Posology (1) | Possible mechanisms (1) |
| Post marketing (1) | Post SARS-COV-2 infection (1) | Post-antibiotic era (1) |
| Posterior reversible encephalopathy syndrome (1) | Potassium (1) | Potassium Channel (1) |
| Potassium chloride (1) | Potassium Nitrate (1) | Potential Drug-Drug Interaction (1) |
| Potentially malignant lesions (1) | POTS (1) | Powder (1) |
| PPAR agonists (1) | PPARγ agonists. (1) | PPBG (1) |
| pPharmacokinetics (1) | PPP model (1) | practice (4) |
| practices (1) | pravastatin (1) | Pre ADMET (1) |
| pre prandial (1) | Pre University students (1) | Pre-authorization (1) |
| Pre-school (1) | Prebiotic (2) | Preceptors (1) |
| Precipitation (1) | precise (1) | Precision (1) |
| Predictors (3) | Pregabalin (1) | Pregnancy (4) |
| preliminary screening (1) | Premna esculenta (1) | Preparedness (1) |
| prescriber (1) | Prescribing (2) | Prescribing errors (2) |
| Prescribing indicators (1) | Prescribing pattern (1) | Prescribing pattern and Prescription Quality (1) |
| Prescribing pattern. (1) | Prescribing Trend (1) | Prescription (3) |
| Prescription audit (1) | Prescription error. (1) | prescription monitoring (1) |
| prescription only medicines (1) | Prescription pattern (3) | Prescription refill (1) |
| Prescription review (1) | pressure dependent approach (1) | Prevalence (5) |
| Prevention. (1) | Price variation (1) | Primary health care (2) |
| Primary Health Care. (1) | Primary tooth (1) | Principal component analysis (1) |
| principal component regression (1) | Pristane (1) | Private Medical College (1) |
| Private sector (1) | PRO (1) | Probable (1) |
| Probiotic (1) | Probiotics (2) | Problem-based learning (1) |
| process capability (1) | Process parameters. (1) | Product Surveillance (1) |
| Products with Antimicrobial Action. (1) | progesterone (1) | Proniosomal gel (1) |
| Property Intellectual (1) | Prophylaxis (2) | propolis (5) |
| Proportional reporting ratio (1) | propranol hydrochloride (1) | Propranolol hydrochloride (1) |
| Prospection (1) | Prospective Study (2) | prostaglandins (1) |
| Prosthesis Coloring (1) | Proteasome activity (1) | protein proÞ le (1) |
| proteolytic enzymes (1) | Proton adduct (1) | Proton Pump Inhibitor (2) |
| Proton pump inhibitors (1) | Proton-pump Inhibitors (1) | Protransfersome (1) |
| Prteomics (1) | Pseudo ternary phase diagrams (1) | Pseudomonas aeruginosa (1) |
| Psidium Guajava (1) | Psychiatric distress (1) | Psychological mindedness (1) |
| Psychomotor (1) | Psychosis (2) | Psychotropic drugs (1) |
| Psychotropics (1) | Pterocarpus indicus (1) | Pterocarpus indicus Willd (1) |
| Public behavior (1) | Public health (1) | Public health hospital (1) |
| Public hospital (2) | Public Service (1) | Publication (1) |
| Publications (2) | Pulmonary Fibrosis (1) | pulmonary hypertension (1) |
| Pulmonary toxicity (1) | Pulpectomy (1) | Pulse wave velocity (1) |
| Punica granatum (2) | Pyrazinamide (1) | pyrazine (1) |
| pyrazoline (1) | pyrazolines (2) | Pyrimidine (1) |
| Q1F (1) | QOL (1) | QRS-T angle (1) |
| QSAR (3) | qualitative (1) | Qualitative analysis (1) |
| qualitative study (1) | Quality (2) | quality assurance (1) |
| Quality by design (QbD) (1) | Quality by design Ritonavir (1) | Quality Control (1) |
| Quality Indicators (1) | quality of internet information (1) | quality of life (9) |
| Quantification (1) | quantitative structure-activity relationship (1) | Quercetin (2) |
| Questionnaire (2) | quinazolin-4(3H)one (1) | quinazolinone (1) |
| Quinazolinone. (1) | quinoline derivatives (1) | R2 values (1) |
| Rabbit plasma (1) | Rabbits. (1) | radical scavenger (1) |
| Radical scavengers (1) | radicals (1) | Radiculopathy (1) |
| Radio-mitigation (1) | Radiology Unit (1) | radiopharmaceuticals (1) |
| radiopharmacy (1) | Radioprotective (1) | Raillietina echinobothrida (1) |
| raloxifene hydrochloride (1) | Raltegravir potassium (1) | Raman spectroscopy (2) |
| ramipril (2) | ranitidine (1) | Ranitidine hydrochloride (2) |
| Ranitidine’. (1) | ranolazine (1) | Ransmission electron microscopy (1) |
| Rapid antigen test (1) | Rapid disintegration (1) | Rasagiline mesylate (1) |
| Rat (1) | ratio test procedures (1) | Rational pharmacotherapy. (1) |
| Rational prescribing (1) | Rational Use (2) | Rational use of Medication (1) |
| Rational use of medicine (1) | rational use of medicines (1) | rats (1) |
| Rattus novergicus (1) | Re-emerging viral infections (1) | re-precipitation (1) |
| Reactants (1) | recognized standards (1) | recovery studies (1) |
| Red ginger (1) | Reduction (1) | Reflective pedagogy paradigm (1) |
| Reflux diseases (1) | reforms (1) | Regeneration (1) |
| Regression analysis (2) | Regressions statistics (1) | Regulation (1) |
| Regulations (1) | regulatory (2) | Regulatory affairs (1) |
| regulatory system (1) | Rehospitalisation (1) | Related substance (1) |
| Relative performance (1) | release kinetics (3) | Release studies. (1) |
| relese kinetics (1) | Removable denture (1) | Renoprotection (1) |
| Renoprotective (1) | repaglinide (2) | reperfusion (1) |
| Repurposing (1) | research (1) | Research Skills. (1) |
| reserpine (1) | Resident doctors (1) | Resistance (6) |
| Resistant starch (1) | Resource poor setting (1) | Respiratory failure (1) |
| Respiratory tract (1) | Response Surface Methodology (3) | Response surface methodology. (1) |
| Response to antiretroviral therapy (1) | Resveratrol (2) | retail pharmacy (1) |
| Retention. (1) | Retinopathy (1) | retrospective cohort (1) |
| Retrospective study (3) | reversed-phase chromatography (1) | Rhabdomyolysis (1) |
| Rhaphidophora pinnata (1) | Rheumatology (1) | rhizomes (1) |
| Riboflavin (1) | Rice Bran Oil (1) | Rifampicin (2) |
| Ringer’s dextrose (1) | Ringer’s lactate. (1) | Riociguat (1) |
| Risk Estimation Matrix (1) | Risk factor. (1) | Risk factors (5) |
| Risk Factors. (1) | Risk Groups (1) | Risk rating (1) |
| Rituximab (1) | rivastigmine (1) | RNA interference (1) |
| RNAi (1) | RNAi technology (1) | RNTCP (2) |
| Rodenticides (1) | root (1) | Root canal filling materials (1) |
| Root canal infection (1) | Roots extract (2) | Ropinirole (1) |
| Roscoea purpurea (1) | rosuvastatin (2) | rosuvastatin calcium (1) |
| Rota rod test (1) | Royal Malaysian Custom Officer (1) | RP-HPLC (9) |
| RP-HPLC method (1) | RP-TLC/Densitometry (1) | RP-UFLC method (1) |
| RT-qPCR (1) | Rubus fraxinifolius (1) | Rubus rosifolius (1) |
| rupatadine (1) | rutin (1) | ß avonoids (2) |
| S. mutans (1) | S.salivarius (1) | S.sanguis (1) |
| Saccharin (1) | Safe handling guidelines (1) | Safety (1) |
| Safoof razyanaj (1) | Safoof-e- Binai (1) | Sage (1) |
| Sambung nyawa (1) | Saponin (2) | saponins (1) |
| Sappan wood (1) | Saraschandra (1) | Satisfaction (1) |
| Saudi Arabia (9) | Saudi National Pharmacovigilance Centre (Saudi NPC) (2) | Saussurea (1) |
| Saussurea lappa (1) | scanning electron microscopy (3) | Schizophrenia (3) |
| Scientific Advertisements (1) | Scientometrics (6) | sclerotherapy (1) |
| Scopolamine (1) | Scores. (1) | Scorpions (1) |
| Se- DeM ODT Expert system (1) | Second-line agents (1) | Secondary Level (2) |
| Sedation (1) | Sedation in pediatric patients (1) | Sedation scale (1) |
| seizure outcome (1) | Seizures (1) | Selected area electron diffraction (1) |
| Self efficacy. (1) | Self medication (1) | Self-directed learning (1) |
| self-emulsifying drug delivery system (1) | Self-Harm (1) | self-medication (7) |
| Self-Nano Emulsifying Drug Delivery System (SNEDDS) (1) | self-nanoemulsification (1) | Selfmedication (1) |
| Semi-permanent hair dye (1) | senna spectabilis (1) | Sensitive (1) |
| sensory cortical activity. (1) | separation (1) | sepbox (1) |
| Septic shock (1) | Sequences distillation (1) | Sequential optimization (1) |
| Serum (1) | Serum Ferritin (1) | Serum Glutamate-Pyruvate Transaminase (1) |
| Serum Glutamic Oxaloacetic Transaminase (1) | Serum triglyceride (1) | Serum Vitamin D (1) |
| Serum. (1) | sesame oil (1) | Severe acute respiratory syndrome coronavirus 2 (1) |
| Severe acute respiratory system coronavirus 2 (1) | severe febrile neutropenia (1) | Severe Neck Pain (1) |
| Severe sepsis (1) | Severity (2) | Sexual dysfunction in diabetes (1) |
| Sexuality (1) | SF-36 (1) | SGLT-2 Inhibitor (1) |
| Shark liver oil and Wound healing activity (1) | Shodhana (1) | Short Communication (3) |
| short-term memory (1) | Sida rhomboidea.Roxb (1) | Side effect (1) |
| Side effects (1) | signal detection (1) | Signal detection. (1) |
| Signs and Symptoms (1) | Signs and Symtoms (1) | Silver nanoparticles (1) |
| silymarin (2) | Similarity factor (1) | similarity factor (f2) (2) |
| simplex lattice (1) | Simplex Lattice Design (2) | simultaneous determination (2) |
| simultaneous extraction (1) | simvastatin (1) | simvastatin. (1) |
| Single nucleotide polymorphism (1) | sintering (1) | siRNA (1) |
| siRNA. (2) | SIRT1 (1) | Sirtuin (1) |
| Sitagliptin (1) | Sitagliptin phosphate (1) | six sigma (1) |
| SJS (1) | Skin diseases (1) | Skin drug test (1) |
| Skin irritation (1) | Skin protection (1) | Skin whitening (1) |
| SLAM markers (1) | SLS (1) | Smix (1) |
| Smix. (1) | Smoking (1) | smoking cessation. (1) |
| Smoking. (1) | smooth muscle cells (1) | Snake bite (1) |
| SNEDDS (2) | sobatum (1) | Social Media (1) |
| Social sexual. (1) | Sociodemographic factors (1) | Socioeconomic status (1) |
| SOD (1) | Sodium (1) | sodium alginate (1) |
| sodium alginate. (2) | sodium carboxy methyl cellulose (1) | sodium starch glycolate (3) |
| Sodium starch glycolate (SSG) (1) | Sodium Valproate (1) | Sofosbuvir (1) |
| Solanum nigrum (1) | Solanum trilobatum (1) | Solanum viarum (1) |
| Solanum xanthocarpum, (1) | Solasodine (1) | solid dispersion (5) |
| solid lipid nanoparticles (1) | Solid lipid nanoparticles. (1) | Solid Phase Extraction (1) |
| solubility (7) | Solubility enhancement (1) | Solubility. (1) |
| solvent casting (1) | solvent evaporation (4) | Solvent evaporation. (1) |
| sonication time (1) | sonophoresis (1) | Sorafenib (1) |
| Sources (1) | Spacedrepetition. (1) | spasmolytic (1) |
| speciÞ city (1) | Spectrometric (1) | spectrophotometry (2) |
| sperm count (2) | SPF (1) | Spiro compounds (1) |
| Spleen colony assay (1) | Spondylosis (1) | Sponge implantation (1) |
| sponge implantation assay (1) | sponsors (1) | Spontaneous-Reporting. (1) |
| Sprague Dawley (1) | spray drying (1) | SPSS 20. (1) |
| Sri Lanka (1) | ST segment elevation (1) | stability (2) |
| stability indicating (1) | stability indicating and validation. (1) | Stability indicating assay (1) |
| Stability indicating assay method (1) | stability indicating method of artemether (1) | stability indicating. (1) |
| Stability of the physical properties (1) | Stability test (1) | stability. (1) |
| stain removal (1) | stakeholders (1) | Standardization (7) |
| Standardized Zscore (1) | Staphylococcus aureus (1) | Staphylococcus sciuri (1) |
| Starlac (1) | Statin pathway (1) | Statins. (1) |
| Statistical Modeling (1) | Statistical optimization (1) | Stelechocarpus burahol (1) |
| Stem bark extract (1) | Stephania hernandifolia (1) | Stereospermum suaveolens (1) |
| Stereospermum tetragonum (2) | Sterilization Procedures (1) | Steroidal alkaloid (1) |
| Steudnera colocasiifolia (1) | Stevens Johnson Syndrome (1) | Stevens-Johnson syndrome (1) |
| Stilbene (1) | Stimulantia (1) | Stimuli (1) |
| Stomatitis under prosthesis (1) | Strabismus surgery (1) | Streptococci (1) |
| Streptococcus mutans (4) | Streptokinase (1) | Streptomonospora arabica (1) |
| Streptomyces (1) | Streptozotocin (2) | Streptozotocin (STZ) (1) |
| streptozotocin-induced diabetes (1) | Streptozotocin. (1) | stress (3) |
| Stress degradation (1) | stress studies (2) | stroke and cardiac pacemaker. (1) |
| Stroke prevention (1) | structural descriptor (1) | Structured Communication. (1) |
| Stryphnodendron rotundifolium (1) | students (4) | students’ residence (1) |
| Sub Clinical Hypothyroidism. (1) | Sub-acute Inflammation (1) | Subcutaneous fat (1) |
| sublingual films (1) | substituted acetophenones (1) | Succinic acid (1) |
| sucrase (1) | Sudan (1) | Sulfated polysaccharides (1) |
| Sulfonylurea (2) | Sulfonylureas (1) | Sulphorhodamine-B (1) |
| Sun (1) | sun protection factor (2) | Sunlight (1) |
| Sunscreens. (1) | Super disintegrants (1) | superdisintegrants (2) |
| Superdisintergrants (1) | Superoxide Dismutase. (1) | superoxidedismutase (1) |
| superporous hydrogel composite (1) | Supply Chain Management (1) | support staff. (1) |
| Supportive care (1) | Surface properties (1) | surfactant (1) |
| surfactants (2) | Surgery (2) | Surgical cutters (1) |
| surgical prophylaxis. (1) | Surgical. (1) | Survey questionnaire (1) |
| survey. (1) | Survival rate (1) | sustained release (3) |
| sustained release pellets (1) | sustained release. (1) | Susutained release layer (1) |
| Sweet orange peel extract (Citrus sinensis) (1) | swelling index (2) | swelling studies (1) |
| SWOT (1) | Symptoms (1) | Symptoms domain (1) |
| Synchronous spectrofluorimetry. (1) | Synergism. (1) | Synthesis (4) |
| Synthesis; 1-allyl-3-benzoylthiourea; COX-2; Analgesic; Lead Compound; (1) | Systematic review (2) | Systematic Review. (1) |
| Systemic steroids. (1) | Systems biotechnology (1) | Systolic dysfunction. (1) |
| T cell epitope (1) | T lymphocytes (1) | T regs (1) |
| Tab. Pardopa (1) | Tablet Compression (1) | Tacrolimus (2) |
| Tacrolimus Once Daily (1) | Tacrolimus Twice Daily. (1) | Tactile stimulation (1) |
| tail suspension test (1) | Tamarindus indica (1) | Tamilians (1) |
| Tamoxifen (1) | Target delivery (1) | Targeted drug delivery system (1) |
| taste masking (2) | tasteless complex (1) | taxane (1) |
| Taxanes (1) | Taxus baccata (1) | Teaching Hospital (1) |
| Technology (1) | technology-enhanced learning (1) | Tecoma stans (1) |
| tegument (1) | telmisartan (1) | Temporomandibular Joint (1) |
| Temporomandibular Joint Disoders (1) | TEN (1) | Tenatoprazole sodium (1) |
| Tengger (1) | Tenofovir disoproxil fumarate (1) | Tephrosia purpurea ethanolic seed extract (TpEt). (1) |
| Tephrosia villosa (1) | Terminala bellerica (1) | Terminalia bellirica (1) |
| Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) | Ternary phase diagram (1) | terpenoids (1) |
| Tertiary Care (1) | Tertiary care hospital (3) | testicular damage (1) |
| testosterone (3) | Tetrapreniltoluquinone (1) | thalassemia major (1) |
| therapeutic angiogenesis (1) | therapeutic dose (1) | therapeutic drug monitoring (2) |
| therapeutic effectiveness (1) | Therapeutic Policies (1) | Thermoreversible gel (1) |
| Third Molar (1) | Thixogel (1) | Thixotropic (1) |
| THP-1 (2) | Three component system (1) | thrombocytopenia (1) |
| Thrombolysed subjects (1) | Thrombolytic (1) | thrombolytic enzymes (1) |
| Thyme oleoresin (1) | Thyrotoxicosis. (1) | Tigecycline (1) |
| time dependent approach (1) | Time lag (1) | Timed release (1) |
| Tissue distribution (1) | Tityus (1) | TLC (1) |
| Tobacco (2) | Tobacco smoking (1) | tolbutamide (1) |
| Tolerance (1) | Tooth brush. (1) | Tooth brushing (1) |
| Tooth Demineralization (1) | Toothbrushing (1) | Toothpaste (1) |
| Toothpaste. (1) | Topical delivery. (1) | Topical drug delivery system (1) |
| Topical. (1) | Total flavonoid (1) | Total flavonoid content (2) |
| Total phenolic (2) | Total phenolic content (1) | total polyphenolic content (1) |
| total quality management (1) | toxicity (5) | Toxicity. (2) |
| traditional medicine (2) | Training of Central sterile and supply department employees (1) | tramadol HCL (1) |
| Tramadol Hydrochloride (1) | Trans-cinnamic acid (1) | Trans-resveratrol (1) |
| Transcriptomics. (1) | transdermal (2) | transfer latency (1) |
| Transfersome (2) | Transfersomes (1) | Transfersomes. (1) |
| Translation (1) | Transmucosal (1) | Transmucosal patch (1) |
| Trauma induced external inflammatory root resorption (1) | Treatment (1) | Treatment adherence. (1) |
| Treatment outcomes (1) | Treatment success rate (1) | Triacylglycerol. (1) |
| Triamcinalone Acetonide (TRIA) (1) | Trichoderma reesei. (1) | Tricyclic antidepressants (TCA) (1) |
| Triglycerides (1) | Trigonella foenum graecum (1) | Trigonelline (1) |
| Trinidad & Tobago (1) | trinitrobenzene sulfonic acid (1) | Triphala (2) |
| triple distilled water (1) | Triterpenoid. (1) | Triterpenoids (1) |
| Triticum aestivum. (1) | Tropaeolum majus L (1) | tropicamide (1) |
| Troponin-I (1) | Trypsin (1) | TSLP (1) |
| Tuberculosis (5) | Tuberculosis/HIV (1) | Tumor response (1) |
| Turkey (1) | Turmeric (1) | Turpentine oil (1) |
| Tween 80. (1) | Twisted (1) | Tylophora indica (1) |
| Tylophorinidine. (1) | type 2 diabetes (2) | Type 2 diabetes mellitus (1) |
| Type 2 diabetes mellitus. (1) | type 2 diabetes. (1) | UACR (1) |
| UCPMP Guidelines (1) | Ultra violet detection (1) | Ultra-Fast Liquid Chromatography (UFLCDAD) (1) |
| Ultrasonic assisted extraction (1) | ultrasonication-solvent evaporation technique (1) | Ultrasonography (1) |
| Unani (1) | Unani medicine (3) | Uncemented (1) |
| Underutilization of insulin. (1) | Unethical practices. (1) | Unique device identification (1) |
| Universal health coverage (1) | Universities (1) | Unlicensed. (1) |
| Unnecessary use. (1) | Unused drugs (1) | Unused/Unwanted medicines (1) |
| UPLC-QToF-MS/MS (1) | UPLC/ESI-Q-TOF-MS/MS method Validation (1) | Urban area (1) |
| urea (2) | Uremic toxins (1) | Urinary Hydrogen Peroxide (1) |
| Urinary Tract Infection (1) | Urinary tract infection (UTI) (1) | Urine Albumin to Creatinine Ratio (1) |
| Urine volume (1) | urolithiasis (1) | Urtica dioica L (1) |
| URTIs (1) | Usefulness. (1) | Uterine fibroid (1) |
| Uterine fibroids (1) | Uterine Perforation. (1) | Utilization Pattern (1) |
| UV derivative spectrophotometry (1) | UV detection (2) | UV Spectrophotometric method (1) |
| UV spectrophotometry (2) | UV Spectroscopy (1) | UV-spectrophotometric method (1) |
| UV-spectrophotometry (2) | UV-Vis spectroscopy (1) | Vaccine (2) |
| Vaccine design (1) | vada (1) | vaginal gel (1) |
| Vaginitis. (1) | Vakrasana (1) | validation (21) |
| Validation. (1) | Valium (1) | Valproate (1) |
| valsartan (1) | Vanillin (1) | Vanillosmopsis arborea. (1) |
| vascular bundle (1) | vascular permeability (2) | vascular progenitors (1) |
| VED analysis (3) | VED analysis. (2) | VEGFR-2 (1) |
| Velpatasvir (1) | Venetoclax (1) | Venography and Hemangioma (1) |
| Venous malformations (VMs) (1) | verapamil (3) | Verapamil HCl (1) |
| Viability (1) | Vincristine. (1) | Vinegar (1) |
| VIPPS (Verified Internet Pharmacy Practice Sites) (1) | Virtual Screening (1) | Viscosity (1) |
| visible Spectrophotometry (1) | visible spectroscopy (1) | Visual analogue scale. (1) |
| Visual Analogues Score. (1) | Vitamin B12 (1) | Vitamin D (3) |
| Vitamin D deficiency (2) | Vitamin D. (1) | vitamin E (1) |
| vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) | Vitamin. (1) | Vitamins (1) |
| Vitex agnus Castus (1) | Vitex negundo (1) | Vitex negundo Linn (1) |
| Voltage–gated calcium channels (1) | Voriconazole (1) | warfarin (2) |
| Warning signs (1) | Water hyacinth (2) | web-based learning (1) |
| Weibull parameters (1) | West timor (1) | Western blot technique (1) |
| Wet gangrene (2) | wet granulation (2) | wetting time (1) |
| Wheat (1) | White/red patch (1) | WHO core indicators (1) |
| WHO prescribing indicator (1) | WHO-QOL BREF questionnaire (1) | WHO-UMC causality assessment system. (1) |
| Wilson disease (1) | Wistar rats. (1) | Withania somnifera. (1) |
| Withdrawal (1) | Women. (1) | Work protection (1) |
| Work Satisfaction (1) | World Anti-Doping Agency (1) | World Health Organization (1) |
| Worldwide (1) | Wound Healing (1) | Wound tissue healing (1) |
| Wrightia tinctoria (1) | writhing (1) | X-ray diffraction (1) |
| X-ray imaging study. (1) | X-ray powder diffraction (1) | xanthan gum (1) |
| Xanthangum (1) | XDR-TB (1) | Xenografts (1) |
| Xenografts. (1) | XRD (1) | Xylitol (2) |
| Ylang-ylang (1) | Yoga (1) | Young (1) |
| Yucca gloriosa L. (1) | Zea m1 pollen allergen (1) | Zero order release (1) |
| zero order spectrophotometry (1) | zeta potential (1) | zidovudine (2) |
| Zika virus (1) | zinc (1) | Zinc ion (1) |
| Zingiber officinale (1) | Zingiberaceae (1) | zopiclone (1) |
| [BMIM]PF6 (1) | Þ rst-order derivative spectroscopy (1) | Α-amylase (3) |
| α-glucosidase (2) | α-mangostin (1) | α1 adrenergic antagonist (1) |
| β amyloid protein (1) | β Amyloid1-42 (1) | β-carboline (1) |
| β-carotene production (1) | β-cyclodextrin (3) | γ-oryzanol (1) |
| γ-retroviral vector (1) | ε-amino groups (1) | |
